Minimed Group, Inc.
MMED
$12.34
$0.322.66%
NASDAQ
| 01/23/2026 | 10/24/2025 | 07/24/2025 | |||
|---|---|---|---|---|---|
| Revenue | 14.99% | 13.11% | 13.11% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 14.99% | 13.11% | 13.11% | ||
| Cost of Revenue | 44.52% | 10.40% | 10.40% | ||
| Gross Profit | -6.84% | 15.27% | 15.27% | ||
| SG&A Expenses | 15.30% | 7.28% | 7.28% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | 557.14% | 240.00% | 240.00% | ||
| Total Operating Expenses | 31.88% | 9.81% | 9.81% | ||
| Operating Income | -495.45% | 195.24% | 195.24% | ||
| Income Before Tax | -571.43% | 110.00% | 110.00% | ||
| Income Tax Expenses | -57.14% | 666.67% | 666.67% | ||
| Earnings from Continuing Operations | -1,485.71% | 8.70% | 8.70% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -166.67% | 0.00% | 0.00% | ||
| Net Income | -1,090.00% | 6.45% | 6.45% | ||
| EBIT | -495.45% | 195.24% | 195.24% | ||
| EBITDA | -181.36% | 108.51% | 108.51% | ||
| EPS Basic | -1,088.64% | -- | -- | ||
| Normalized Basic EPS | -710.75% | -- | -- | ||
| EPS Diluted | -1,088.64% | -- | -- | ||
| Normalized Diluted EPS | -710.75% | -- | -- | ||
| Average Basic Shares Outstanding | 0.00% | -- | -- | ||
| Average Diluted Shares Outstanding | 0.00% | -- | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||